ViQi’s Optimized System
To achieve speed, rigor and compliance - we’ve created a “system” that includes Control based Auto-ML, Platform, Validation & Compliance
Ensuring that every assay is as secure as it is innovative.
At ViQi we believe that imaging cells and tissues unlocks a vast untapped potential to improve and optimize the entire drug discovery pipeline. Data analysis is the current bottleneck for this reality. To this goal, we have designed a builder for predictive AI assays that dramatically simplifies the assay automation process. Compliance is woven into every assay, starting with ViQi’s platform FDA registration as a Class I Medical Device Data System (MDDS).
ViQi’s proprietary SaaS platform operationalizes automatic assay building, enabling processing of terabytes of data with high precision.
Predictive AI
ViQi’s AI-driven engine enables precision and speed, turning complex data into actionable results that align with your unique objectives.
Our assays follow a proprietary Phenotypically Targeted AI (PTA™) approach which automates and operationalizes predictive AI assay creation. With our innovative system, each tool is crafted to help you discover faster and more accurately, paving the way for groundbreaking advancements in drug discovery and precision medicine.
Examples our Phenotypically Targeted AI can address:
Lack of a clear biological marker or reporter to understand underlying mechanisms.
Manual cell or colony counting, which is prone to human error and time-consuming.
Difficulty in predicting the toxicity of new drug candidates.
Existing assays that are often:
–Too slow
–Unable to handle high sample volumes
–Insensitive
And more–The list is limitless.
Drug Discovery–faster and more accurately.
SaaS Platform
ViQi’s platform functions as a powerful, adaptable workbench, where advanced AI capabilities and robust imaging technologies come together to build custom assays tailored to specific research needs.
Serving as a centralized, cloud-based hub, the platform provides all the tools required to develop, validate, and refine AI-driven assays with precision and efficiency.
It supports vast data management and high-throughput image analysis, enabling seamless integration and collaboration across teams. This workbench approach ensures that scientists can quickly create, test, and optimize assays, all within a secure, compliant environment. By simplifying complex assay development workflows, ViQi’s platform accelerates the journey from data collection to actionable insights, empowering researchers to push the boundaries of drug discovery and personalized medicine.
Validation Tools
At ViQi, compliance and validation are foundational, ensuring our AI-driven platform meets the highest regulatory standards. As an FDA-registered Class I MDDS, our platform embeds quality, safety, and efficacy in every assay. We work with our customers to rigorously validate each assay per ICH standards, verifying accuracy, specificity, and robustness for reliable, reproducible results across diverse applications.
